New Cancer Treatment Options: Clinical Study at Sarah Cannon UCF Lake Nona

New Treatment Avenues Explored

• 💉 An endplate injection was administered to increase platelet counts above 100, a requirement for eligibility in clinical studies.
• 📝 Paperwork was signed for a second clinical study with Dr. Perez at the Sarah Cannon UCF Lake Nona Cancer Center, offering a new potential treatment path.
• ⏳ There is a three-week waiting period for the endplate injection to take effect before eligibility for clinical studies can be confirmed.

Understanding the Antibody-Drug Conjugate Study

• 🔬 The new study involves an antibody-drug conjugate, which specifically binds to and is absorbed by cancer cells, destroying their key processes.
• 💣 This targeted approach is described as a "bomb" that selectively attaches to tumors and kills the cells, unlike general chemotherapy.
• ✅ This particular study is in Phase One, meaning all participants receive the investigational drug, contrasting with another study that has a 50/50 chance of receiving the drug or chemotherapy.

Urgency and Personal Health Update

• ⚠️ There is pressure to start the next phase of treatment soon, as several weeks without chemotherapy increase the risk of disease spread, particularly outside the liver.
• 💪 The speaker reports improved appetite and returning energy, despite occasional bloating, and is ensuring adequate nutrient intake while off chemo.
• 🧘‍♀️ To manage sleep disturbances, the speaker has adopted strategies like waking up to work or read and has reintroduced daily 10-minute meditation for calm and focus.

Gratitude for Diverse Treatment Options

• 🙏 The speaker expresses gratitude for the multiple treatment options now available, including the Merc study and Dr. Perez's study, after a period of uncertainty.
• 🏥 Central Florida offers a wealth of resources, including Advent Health Cancer Institute, Orlando Health, Sarah Cannon Research Institute, Mayo Clinic, and Moffett Cancer Institute, all within a few hours' drive.
• 🎯 The ultimate goal is to reach No Evidence of Disease (NED), and the availability of these options provides significant optimism for continuing the fight against cancer.